These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37949150)

  • 1. Impact of the new European respiratory (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction.
    Chaiwong W; Deesomchok A; Pothirat C; Duangjit P; Liwsrisakun C
    Respir Med; 2023 Dec; 220():107460. PubMed ID: 37949150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
    Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
    Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
    [No Abstract]   [Full Text] [Related]  

  • 3. Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.
    Li Y; Lin J; Wang Z; Wang Z; Tan L; Liu S; Huang J; Gao Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2623-2633. PubMed ID: 36274994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 5. Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
    Kim J; Kim WJ; Lee CH; Lee SH; Lee MG; Shin KC; Yoo KH; Lee JH; Lim SY; Na JO; Hwang HG; Hong Y; Lim MN; Yoo CG; Jung KS; Lee SD
    Respir Res; 2017 May; 18(1):107. PubMed ID: 28558829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Fortis S; Quibrera PM; Comellas AP; Bhatt SP; Tashkin DP; Hoffman EA; Criner GJ; Han MK; Barr RG; Arjomandi M; Dransfield MB; Peters SP; Dolezal BA; Kim V; Putcha N; Rennard SI; Paine R; Kanner RE; Curtis JL; Bowler RP; Martinez FJ; Hansel NN; Krishnan JA; Woodruff PG; Barjaktarevic IZ; Couper D; Anderson WH; Cooper CB;
    Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness.
    Beasley R; Hughes R; Agusti A; Calverley P; Chipps B; Del Olmo R; Papi A; Price D; Reddel H; Müllerová H; Rapsomaniki E
    Am J Respir Crit Care Med; 2024 Feb; 209(4):390-401. PubMed ID: 38029294
    [No Abstract]   [Full Text] [Related]  

  • 8. Argument for changing criteria for bronchodilator responsiveness.
    Hansen JE; Sun XG; Adame D; Wasserman K
    Respir Med; 2008 Dec; 102(12):1777-83. PubMed ID: 18701269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'clinically significant' bronchodilator responsiveness (BDR) in children: a comparative study between six definitions of scholarly societies and a mini-review.
    Guezguez F; Knaz H; Anane I; Bougrida M; Ben Saad H
    Expert Rev Respir Med; 2021 Jun; 15(6):823-832. PubMed ID: 33750253
    [No Abstract]   [Full Text] [Related]  

  • 10. Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV
    Quanjer PH; Ruppel GL; Langhammer A; Krishna A; Mertens F; Johannessen A; Menezes AMB; Wehrmeister FC; Perez-Padilla R; Swanney MP; Tan WC; Bourbeau J
    Chest; 2017 May; 151(5):1088-1098. PubMed ID: 28040521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease.
    Reid DW; Soltani A; Johns DP; Bish R; Williams TJ; Burns GP; Walters EH
    Intern Med J; 2003 Dec; 33(12):572-7. PubMed ID: 14656230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
    Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approach to continuous adventitious respiratory sound analysis for the assessment of bronchodilator response.
    Lozano-García M; Fiz JA; Martínez-Rivera C; Torrents A; Ruiz-Manzano J; Jané R
    PLoS One; 2017; 12(2):e0171455. PubMed ID: 28178317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
    Lu L; Wu F; Peng J; Wu X; Hou X; Zheng Y; Yang H; Deng Z; Dai C; Zhao N; Zhou K; Wan Q; Tang G; Cui J; Yu S; Luo X; Yang C; Chen S; Ran P; Zhou Y
    Respir Res; 2024 Mar; 25(1):149. PubMed ID: 38555433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters.
    Kraemer R; Smith HJ; Gardin F; Barandun J; Minder S; Kern L; Brutsche MH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2487-2500. PubMed ID: 34511893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of forced inspiratory vital capacity to identify bronchodilator reversibility in obstructive lung disease.
    Biring MS; Madison S; Mohsenifar Z
    J Asthma; 2001 Sep; 38(6):495-500. PubMed ID: 11642416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.
    Hanania NA; Sharafkhaneh A; Celli B; Decramer M; Lystig T; Kesten S; Tashkin D
    Respir Res; 2011 Jan; 12(1):6. PubMed ID: 21219660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry.
    Cottee AM; Seccombe LM; Thamrin C; King GG; Peters MJ; Farah CS
    Chest; 2020 Jun; 157(6):1435-1441. PubMed ID: 31982392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.